European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

Francesco Panzuto; John Ramage; D Mark Pritchard; Marie-Louise F van Velthuysen; Joerg Schrader; Nehara Begum; Anders Sundin; Massimo Falconi; Dermot O'Toole

doi:10.1111/jne.13306

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3

J Neuroendocrinol. 2023 Aug;35(8):e13306. doi: 10.1111/jne.13306. Epub 2023 Jul 4.

Authors

Francesco Panzuto¹, John Ramage², D Mark Pritchard³, Marie-Louise F van Velthuysen⁴, Joerg Schrader⁵, Nehara Begum⁶, Anders Sundin⁷, Massimo Falconi⁸, Dermot O'Toole⁹

Affiliations

¹ Department of Medical-Surgical Sciences and Translational Medicine, Digestive Disease Unit, Sant'Andrea University Hospital, ENETS Center of Excellence, Sapienza University of Rome, Rome, Italy.
² Department of Gastroenterology, Hampshire Hospitals and ENETS Center, Kings Health Partners London, London, United Kingdom.
³ Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
⁴ Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
⁵ Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁶ Department for General-, Visceral-, Thoracic- and Endocrine Surgery, Johannes-Wesling-Klinikum Minden, University Hospital of the Ruhr-University Bochum, Bochum, Germany.
⁷ Department of Surgical Sciences, Radiology & Molecular Imaging, Uppsala University, Uppsala, Sweden.
⁸ Pancreas Translational and Clinical Research Center, Pancreatic Surgery Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁹ National Centre for Neuroendocrine Tumours, ENETS Centre of Excellence, St. Vincent's University Hospital, Dublin, Ireland.

PMID: 37401795
DOI: 10.1111/jne.13306

Abstract

The aim of the present guidance paper was to update the previous ENETS guidelines on well-differentiated gastric and duodenal neuroendocrine tumours (NETs), providing practical guidance for specialists in the diagnosis and management of gastroduodenal NETs. Type II gastric NETs, neuroendocrine carcinomas (NECs), and functioning duodenal NETs are not covered, since they will be discussed in other ENETS guidance papers.

Keywords: duodenal neuroendocrine tumours; gastric carcinoids; guidelines; management; prognosis.

MeSH terms

Carcinoma, Neuroendocrine*
Humans
Neuroendocrine Tumors* / diagnosis
Neuroendocrine Tumors* / pathology
Neuroendocrine Tumors* / therapy
Societies
Stomach Neoplasms* / diagnosis
Stomach Neoplasms* / pathology